Magic mushroom compound tested as tool to quit meth
NCT ID NCT06899594
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study will test whether psilocybin, the active ingredient in magic mushrooms, is safe and tolerable for people trying to quit methamphetamine. Twenty adults in northern Louisiana who want to stop using meth will receive psilocybin in a controlled setting. Researchers will track how many people stay in the study, whether they reduce or stop meth use, and how their mood and quality of life change.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
LSU Health Shreveport
RECRUITINGShreveport, Louisiana, 71103, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic help break meth addiction in people with HIV?
- Weight-Loss drug may curb stimulant cravings, brain scans suggest
- Could an antidepressant help curb meth use in people treated for opioid addiction?
- Hormone therapy shows promise in preventing relapse in postpartum meth users
- Could ketamine therapy help people quit meth?
- Could a diabetes drug curb ice addiction? new trial aims to find out